Most people with type 2 diabetes are checked for eye disease only after the retina already shows visible harm, which leaves a narrow window for prevention. A clinical proteomics study in PLoS Medicine took a different route. The team measured thousands of circulating blood proteins and asked which ones forecast retinal nerve fiber loss years before it surfaces on imaging. Working across a Guangzhou cohort and UK Biobank, they tied 71 plasma proteins to diabetic retinal neurod

Pregnant patients were left out of nearly every early COVID-19 trial, so clinicians had little to explain why some expectant mothers deteriorated while others barely noticed the infection. Our team went after that with chemistry instead of clinical scores. In a prospective UCLA cohort, Dalton Bioanalytics scientists co-authored a multi-omics study that profiled maternal serum across proteins, lipids, and metabolites in one LC-MS workflow. Severe illness carried a serum signat

```html Campylobacter jejuni sits quietly in the chicken gut, leaving no clinical signs while it seeds roughly half of slaughtered poultry and drives about 95 million human gastroenteritis cases each year. That silence is the problem. Flocks look healthy right up to processing, so contamination is hard to flag early. Our Dalton Bioanalytics scientists co-authored this multi-omics study, part of our published research, which profiled proteins, lipids, and metabolites together

Wooden breast and spaghetti meat cost United States poultry producers somewhere between $200 million and $1 billion a year, and the molecular triggers stay murky. Transcript counts rarely predict the proteins and lipids that actually shape muscle texture. A 2025 Poultry Science Association symposium paper, which our Dalton Bioanalytics scientists co-authored, sets out how multi-omics built on mass spectrometry connects genomics, transcriptomics, proteomics, metabolomics, and

Psychiatric and developmental conditions in 22q11.2 deletion syndrome (22q11.2DS) are common, yet clinicians have had no reliable blood test to flag who is at risk or to track disease over time. In a study our Dalton Bioanalytics scientists co-authored with the UC Davis MIND Institute, we asked a direct question: can untargeted metabolomics and proteomics read coordinated molecular changes in plasma that single-layer tests miss? Profiling proteins and metabolites together tur